Gene · 3660
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of multiple machine learning approaches to determine key pyroptosis molecules in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 37538791 | PubTator, text mining | PubMed |
| Tryptophan metabolism promotes immune evasion in human pancreatic β cells. | EBioMedicine | 2023 | 37536063 | PubTator, text mining | PubMed |
| EpiMix is an integrative tool for epigenomic subtyping using DNA methylation. | Cell Rep Methods | 2023 | 37533639 | PubTator, text mining | PubMed |
| NLRP3: a new therapeutic target in alcoholic liver disease. | Front Immunol | 2023 | 37520548 | PubTator, text mining | PubMed |
| Expression of Interferon Regulatory Factor 8 (IRF8) and Its Association with Infections in Dialysis Patients. | Cells | 2023 | 37508555 | PubTator, text mining | PubMed |
| Ferroptosis in Cancer Progression. | Cells | 2023 | 37508485 | PubTator, text mining | PubMed |
| Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia. | Sci Rep | 2023 | 37507442 | PubTator, text mining | PubMed |
| The role of IFN-γ-signalling in response to immune checkpoint blockade therapy. | Essays Biochem | 2023 | 37503572 | PubTator, text mining | PubMed |
| The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes. | NAR Cancer | 2023 | 37502711 | PubTator, text mining | PubMed |
| Transient HSP90 inhibition enhances the sensitivity of mantle cell lymphoma to poly (ADP-ribose) polymerase (PARP) inhibitors. | Genes Dis | 2023 | 37492733 | PubTator, text mining | PubMed |
| Identification of mammalian transcription factors that bind to inaccessible chromatin. | Nucleic Acids Res | 2023 | 37486787 | PubTator, text mining | PubMed |
Systematic Review of Neovascular Age-Related Macular Degeneration Disease Activity Criteria Use to Shorten, Maintain or Extend Treatment Intervals with Anti-VEGF in Clinical Trials: Implications for Clinical Practice. | Ophthalmol Ther | 2023 | 37477856 | PubTator, text mining | PubMed |
| The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy. | Biomed J | 2023 | 37467968 | PubTator, text mining | PubMed |
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study. | BMC Cancer | 2023 | 37464378 | PubTator, text mining | PubMed |
| Targeting transcription factors for therapeutic benefit in rheumatoid arthritis. | Front Immunol | 2023 | 37457726 | PubTator, text mining | PubMed |
Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review. | Front Pharmacol | 2023 | 37448961 | PubTator, text mining | PubMed |
| Antiviral and Immunomodulatory Activities of Clinacanthus nutans (Burm. f.) Lindau. | Int J Mol Sci | 2023 | 37445964 | PubTator, text mining | PubMed |
| Liver in infections: a single-cell and spatial transcriptomics perspective. | J Biomed Sci | 2023 | 37430371 | PubTator, text mining | PubMed |
| IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation. | Nat Commun | 2023 | 37429848 | PubTator, text mining | PubMed |
| Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma. | Cancer Genet | 2023 | 37418972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3660/papers?page=11